BRAIN CANCER

This study tested a drug called VAL-083 combined with standard radiation for people newly diagnosed with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to find a safe dose and see if the combination helps control th…

This early study tested a new imaging technique that combines a special tracer called [18F]PARPi with PET/MR scans to take clearer pictures of brain tumors. Five adults with new or suspected returning brain tumors took part. The goal was to see how well the tracer highlights tumo…

This study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…

This study tested a special counseling program called CALM (Managing Cancer and Living Meaningfully) for people with brain cancer. 60 participants were split into two groups: one received CALM plus usual care, the other just usual care. The goal was to see if CALM is practical an…

This study tested whether a simple walking program, tracked with fitness trackers, could help people with various cancers (brain, head and neck, lung, gastrointestinal, or cervical) complete their planned chemoradiotherapy without missing treatments. 166 adults who could walk ind…

This study tested a new cognitive rehabilitation program for brain cancer survivors who have trouble with thinking and memory. 27 survivors and their carers took part. The program aimed to help with daily thinking skills and quality of life. Results will show if the program is he…

This study tested whether a digital social network assessment tool plus a caregiver navigator could reduce stress and burden for family caregivers of brain cancer patients. About 296 caregivers and patients took part. The program measured anxiety, depression, and overall well-bei…

This study gathered medical information and biological samples from over 1,200 people with brain or spinal cord tumors. The goal was to learn more about these cancers and identify new areas for research. Participants provided blood, tissue, and other samples, and completed survey…

This study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …